Multidrug-resistant Organism and Clostridium difficile Infection (MDRO/CDI) Module

The MDRO/CDI Module is part of the Patient Safety Component of NHSN and includes instructions for procedures performing infection surveillance, laboratory-identified (LabID) event reporting, and prevention process and active surveillance testing outcome measures. Prevention process measures include hand hygiene and gown and gloves use adherence. Multidrug-resistant organisms monitored include: methicillin-resistant Staphylococcus Aureus (MRSA), Vancomycin-resistant Enterococcus spp., and Klebsiella spp., Acinetobacter spp. Instructions for monitoring C. difficile infection are also contained in this module.

Corresponding Materials

Protocol and Instructions

• Multidrug-Resistant Organism & Clostridium difficile Infection (MDRO/CDI) Module Protocol [PDF - 255 KB] January 2012
• Tables of Instructions [PDF - 422 KB] January 2012.
  Instructions for completing forms.

Training

• MDRO Infection Surveillance
• LabID Event Reporting
• Prevention Process and Active Surveillance Testing Outcome Measures
• C. difficile Infection Surveillance and C. difficile LabID Event Reporting

Forms

• 57.106 Patient Safety Monthly Reporting Plan [PDF - 56 KB] January 2012
• 57.126 MDRO or CDI Infection Event [PDF - 54 KB] January 2012
• 57.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Reporting [PDF - 42 KB] January 2012
• 57.128 Laboratory-identified MDRO or CDI Event [PDF - 47 KB] January 2012
• 57.108 Primary Bloodstream Infection (BSI) [PDF - 50 KB] January 2012
• 57.111 Pneumonia (PNEU) [PDF - 104 KB] January 2012
• 57.114 Urinary Tract infection (UTI) [PDF - 100 KB] January 2012
• 57.120 Surgical Site Infection (SSI) [PDF - 93 KB] January 2012

Other Resources

• Overview of Methicillin-Resistant Staphylococcus aureus Surveillance through the NHSN [PDF - 97 KB]
  Summary of the main MRSA-related metrics that can be produced by facility data reported to the NHSN through its Multidrug-Resistant Organism and Clostridium difficile Infection (MDRO/CDI) Module and its Device-Associated Module that may be useful in this context.
• A Review of MDRO/CDI Module Improvements since Implementation in March 2009 [PDF - 37 KB]
• Change to the Confer Rights MDRO/CDI Summary Data Section [PDF - 167KB]
• Guide to Analyzing C. difficile Custom Events [PDF - 199KB]
• MDRO/CDI Module LabID Event Specimen Source Codes [PDF - 461KB]